A G Prilipov Selected Research

Human Influenza (Influenza)

11/2020	[The Effect of I155T, K156Q, K156E and N186K Mutations in Hemagglutinin on the Virulence and Reproduction of Influenza A/H5N1 Viruses].
1/2020	Variability of nonpathogenic influenza virus H5N3 under immune pressure.
1/2020	The Effect of I155T, K156Q, K156E and N186K Mutations in Hemagglutinin on the Virulence and Reproduction of Influenza A/H5N1 Viruses.
1/2019	[Evolution of pandemic influenza virus A(H1N1)pdm09 in 2009-2016: dynamics of receptor specificity of the first hemagglutinin subunit (HA1).]
8/2016	Virological, epidemiological, clinic, and molecular genetic features of the influenza epidemic in 2015-2016: prevailing of the influenza A(H1N1)09 pdm virus in Russia and countries of the Northern hemisphere.
1/2016	[The 2015-2016 epidemic season in Russia and the world: Circulation of influenza viruses, trends in incidence, clinical aspects, and treatment algorithm].
3/2014	[The peculiarities of the influenza epidemics in some areas of Russia during 2012-2013 season. The influenza A (H1N1) pdm09 virus domination in European countries].
1/2014	[The 2013-2014 epidemic season. Hospital monitoring and antiviral therapy for influenza ].
5/2013	[Etiology of fatal pneumonia caused by influenza A(H1N1)pdm2009 virus during the pandemic in Russia].
3/2013	[Development of the influenza epidemic in season 2011-2012 in some areas of Russia: results of activity of the Influenza Etiology and Epidemiology Center of the Ivanovsky Institute of Virology].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A G Prilipov Research Topics

Disease

19	Human Influenza (Influenza) 11/2020 - 03/2006
3	Pneumonia (Pneumonitis) 05/2013 - 07/2010
2	Influenza in Birds (Avian Flu) 01/2020 - 03/2006
2	Neoplasms (Cancer) 11/2017 - 01/2017
2	California Encephalitis 01/2011 - 11/2008
1	COVID-19 01/2023
1	Hemolysis 09/2016
1	Viral Pneumonia 01/2012
1	Fever (Fevers) 01/2011
1	Orthomyxoviridae Infections 01/2011
1	Cough 01/2011
1	Rhinitis 01/2011
1	Tracheitis 01/2011
1	Disease Progression 01/2011
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2006
1	West Nile Fever 09/2002
1	Hemophilia A (Haemophilia) 11/2000
1	Hepatitis C 11/2000
1	T-Cell Leukemia (Leukemia, T Cell) 01/2000

Drug/Important Bio-Agent (IBA)

6	Hemagglutinins (Hemagglutinin)IBA 11/2020 - 05/2010
6	Antiviral Agents (Antivirals)IBA 01/2016 - 03/2006
4	VaccinesIBA 01/2023 - 03/2013
4	Oseltamivir (Tamiflu)FDA Link 01/2013 - 09/2009
3	Rimantadine FDA LinkGeneric 01/2012 - 03/2006
2	Monoclonal AntibodiesIBA 11/2017 - 01/2017
2	RNA (Ribonucleic Acid)IBA 05/2013 - 11/2000
2	Neuraminidase (Sialidase)IBA 01/2013 - 09/2009
2	pentanedioic acid imidazolyl ethanamideIBA 01/2011 - 01/2011
2	NucleotidesIBA 01/2011 - 11/2008
2	umifenovirIBA 09/2009 - 03/2006
1	EpitopesIBA 01/2020
1	avian influenza A virus hemagglutininIBA 01/2020
1	sialooligosaccharidesIBA 09/2016
1	Zanamivir (Relenza)FDA Link 01/2013
1	Amino Acids FDA Link 01/2012
1	N 30IBA 01/2011
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2011
1	AcidsIBA 05/2010
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2010
1	AsparagineIBA 05/2010
1	Amantadine (Aman)FDA LinkGeneric 03/2006
1	PolyproteinsIBA 01/2006
1	EnzymesIBA 09/2002
1	AntibodiesIBA 11/2000
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2000

Therapy/Procedure

5	Therapeutics 01/2016 - 07/2010